Rankings
▼
Calendar
DNA Q3 2020 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena
DNA
Ginkgo Bioworks Holdings, Inc.
$412M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$13M
Gross Profit
$12M
86.7% margin
Operating Income
-$34M
-258.7% margin
Net Income
-$26M
-195.9% margin
EPS (Diluted)
$-0.81
QoQ Revenue Growth
+30.9%
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$54M
Stock-Based Comp.
$118,000
← FY 2020
All Quarters
Q4 2020 →
